EFFICACY AND SAFETY OF CHEMOTHERAPY CONTAINING BEVACIZUMAB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WITH MALIGNANT PLEURAL EFFUSION

被引：0
|
作者：
Fujii, Mitsuhiro [1 ]
Iwakami, Shin-Ichiro [1 ]
Ihara, Hiroaki [1 ]
Hara, Munechika [1 ]
Iwakami, Naoko [1 ]
Ishiwata, Toshiji [1 ]
Takahashi, Kazuhisa [2 ]
机构：
[1] Juntendo Univ, Shizuoka Hosp, Dept Resp Med, Shizuoka, Japan
[2] Juntendo Univ, Grad Sch Med, Dept Resp Med, Tokyo, Japan
来源：
RESPIROLOGY | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：87 / 87
页数：1
相关论文
共 50 条
  • [41] Efficacy and Safety Evaluations of Anlotinib in Patients with Advanced Non-small Cell Lung Cancer Treated with Bevacizumab
    Jiang, F.
    Li, J.
    Kong, X.
    Qu, H.
    Sun, P.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S436 - S436
  • [42] Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab
    Jiang, Fenge
    Li, Junxia
    Kong, Xiangshuo
    Sun, Ping
    Qu, Huajun
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [43] Efficacy and safety of oxaliplatin and gemcitabine with bevacizumab in advanced non-small cell lung cancer
    Lilenbaum, Rogerio
    Raez, Luis
    Tseng, Jennifer
    Seigel, Leonard
    Davila, Enrique
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (05) : 511 - 515
  • [44] Efficacy of Bevacizumab Combined with Chemotherapy in Lung Adenocarcinortia-Induced Malignant Pleural Effusion
    Tao, Hong
    Meng, Qiyi
    Liu, Zhe
    Li, Mingzhi
    Shi, Liang
    Tang, Junfang
    Xu, Liyan
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1281 - S1282
  • [45] Relationship of clinicopathological characteristics, EGFR genotyping and prognosis in non-small cell lung cancer patients with malignant pleural effusion
    Zhang, J.
    Zhou, Z. S.
    Su, Y. C.
    Yu, T. Q.
    ANNALS OF ONCOLOGY, 2019, 30
  • [46] Clinical course of asymptomatic malignant pleural effusion in non-small cell lung cancer patients A multicenter retrospective study
    Roh, Jiyeon
    Ahn, Hyo Yeong
    Kim, Insu
    Son, Ju Hyeong
    Seol, Hee Yun
    Kim, Mi Hyun
    Lee, Min Ki
    Eom, Jung Seop
    MEDICINE, 2021, 100 (19) : E25748
  • [47] Utility of atezolizumab plus bevacizumab, carboplatin, and paclitaxel combination for the treatment of advanced non-squamous non-small cell lung cancer patients with malignant pleural effusion
    Hisakane, Kakeru
    Atsumi, Kenichiro
    Seike, Masahiro
    Hirose, Takashi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (09)
  • [48] Evaluation Of The Lent Score As A Prognostic Predictor Of Non-Small Cell Lung Cancer With Malignant Pleural Effusion
    Kato, T.
    Hirose, T.
    Matsui, H.
    Masuda, K.
    Tamura, A.
    Funabiki, A.
    Nakamura, S.
    Mori, A.
    Akashi, S.
    Shimada, M.
    Akagawa, S.
    Kitani, M.
    Hebisawa, A.
    Ohta, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [49] Treatment of malignant pleural effusion in non-small cell lung cancer with VEGF-directed therapy
    Xiang, Zhangqiang
    Deng, Xiangyu
    He, Wenfeng
    Yang, Qian
    Ni, Laichao
    Dehghan Shasaltaneh, Marzieh
    Maghsoudloo, Mazaher
    Yang, Gang
    Wu, Jingbo
    Imani, Saber
    Wen, Qinglian
    ANNALS OF MEDICINE, 2022, 54 (01) : 1357 - 1371
  • [50] The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer
    Wang, Yumin
    Chen, Zengqiang
    Chen, Jie
    Pan, Jingye
    Zhang, Wenhui
    Pan, Qinshi
    Ding, Hongyan
    Lin, Xiaomei
    Wen, Xiushu
    Li, Yangyang
    Meng, Qing H.
    CLINICA CHIMICA ACTA, 2013, 421 : 230 - 235
12345